MDX
Asset Logo

Mindax Limited

πŸ‡¦πŸ‡Ί ASX

⛏️ MINING

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

+ 313.33%
Annual Growth

5 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

2
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Mindax Ltd. engages in the exploration and development of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2004-12-08. The firm's segments include Gold and Iron Ore. The Gold segment includes Meekatharra and Mt Lucky Projects. The Iron Ore segment comprises the Mt Forrest Project. The Meekatharra Gold Project (Meekatharra North), tenement E51/1705, lies within the Murchison Gold Field of Western Australia, approximately 40 kilometers (km) north of Meekatharra and two km south of the Andy Well Gold Mine. The Mt Lucky Gold Project, tenement E38/3336, lies within the Mt Margaret Mineral Field of the north-eastern Goldfields of Western Australia (Laverton Greenstone Belt), approximately seven km east of the Granny Smith gold mine (plant capacity 3.5 million tons per annum) and 12 km southeast of Laverton. The Mt Forrest magnetite iron ore project is operated through a joint venture. The company is exploring a regional infrastructure concept centered around its Mt Forrest project, and other surrounding or neighboring projects.

πŸ“ˆ Performance

Price History

-33.33%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

0%
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.05

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in MDX

2

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

2 days

πŸ’΅ Average investment amount

$606

⏰ Last time a customer invested in MDX

344 days
MDX investor breakdown
πŸ’΅ Income of investors

More than 200k

50%

150k - 200k

100k - 150k

50k - 100k

Less than 50k

50%
πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

100%
πŸ™‹ Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in MDX also invest in...

Vanguard FTSE Emerging Markets Shares ETF

VGE

VGE.AX was created on 2013-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Seeks to track the return of the FTSE Emerging Markets All Cap China A Inclusion Index in Australian dollars, before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

1.60%

πŸ“Š Share price

$73.71 AUD

⛳️ DIVERSIFIED

🌏 GLOBAL

Find Out More

IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks

πŸ™Œ Performance (5Yr p.a)

12.01%

πŸ“Š Share price

$145.18 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡ΊπŸ‡Έ UNITED STATES

VISM.AX was created on 2018-11-09 by Vanguard. The fund's investment portfolio concentrates primarily on small cap equity. The Vanguard MSCI International Small Companies Index ETF seeks to track the return of the MSCI World ex-Australia Small Cap Index in Australian dollars, before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

4.18%

πŸ“Š Share price

$64.81 AUD

🌏 GLOBAL

⛳️ DIVERSIFIED

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

12.27%

πŸ“Š Share price

$126.64 AUD

🌏 GLOBAL

πŸ€– TECHNOLOGY

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax

πŸ™Œ Performance (5Yr p.a)

13.70%

πŸ“Š Share price

$91.59 AUD

🌏 GLOBAL

πŸ€– TECHNOLOGY

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

Melodiol Global Health Ltd. engages in the developing, register and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm develops cannabis, hemp-derived and other plant-based therapeutic, nutraceutical, and lifestyle products. The firm distributes pharmaceuticals internationally, specializing in the distribution of medicinal cannabis products across Australasia, and non-cannabis products in the United Kingdom and Europe. The company also develops and sells beauty and personal care products, produced using plant-based processes, including under the brands Green Goo, Southern Butter and Good Goo. Its segments include Europe, Canada and Asia Pacific. Its Europe segment includes Health House International Limited (HHI), UK division, which distributes pharmaceutical products, and Creso Pharma Switzerland GmbH, which includes the development and commercialization of its nutraceutical products located in Switzerland. Its Canada segment includes Mernova Medicinal Inc, a producer of cannabis products and sells under the Ritual brand.

πŸ™Œ Performance (5Yr p.a)

-19.95%

πŸ“Š Share price

$0.00 AUD

πŸ“¦ LOGISTICS

πŸ™Œ Performance (5Yr p.a)

-19.73%

πŸ“Š Share price

$0.00 AUD

Middle Island Resources Ltd. is an exploration company, which engages in the business of identifying, acquiring, and exploring mineral assets. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-16. The firm is focused on copper and gold minerals. Its 100% owned Barkly Copper-Gold Super Project comprises approximately 16 exploration licenses (13 granted and three applications) cover an aggregate of 6,918 square kilometers (km2). The Barkly tenements extend from outcropping areas near Tennant Creek and the interpreted eastward extensions of prospective Proterozoic stratigraphy that includes the East Tennant Ridge and Burnette Downs Rift corridor beneath shallow to moderate depth Georgina Basin cover. Its prospects include Crosswinds, Eiger and Zermatt. The firm's subsidiary is Barkly Operations Pty Ltd.

πŸ™Œ Performance (5Yr p.a)

-18.26%

πŸ“Š Share price

$0.02 AUD

⛏️ MINING

MedAdvisor Ltd. engages in the provision of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm's segments include Australia, the United States, the United Kingdom and Asia Operations. The firm's products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The firm's subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.

πŸ™Œ Performance (5Yr p.a)

155.56%

πŸ“Š Share price

$0.40 AUD

🩺 HEALTH CARE

Compare
Add to watchlist